Russia's Roszdravnadzor healthcare watchdog has uncovered a shortage of critical HIV medications in 20 Russian regions, the state TASS news agency reported Wednesday.
Each of the regions in question lacks three to five different types of medication, Roszdravnadzor's spokesperson told TASS.
The shortages come after Russia altered state procedures for purchasing HIV medications in a bid to provide more patients with treatment.
In Nov. 2016, Russian authorities centralized procurement, empowering the Health Ministry — instead of regional government bodies — to carry out drug tenders. The Health Ministry is scheduled to make the first shipment of HIV drugs to the regions in April 2017.
Until then, regional authorities are charged with creating a sufficient supply of medications on their own. The Russian government allocated a total of 2.28 billion rubles ($40 million) on for this purpose, TASS reported.
Since 2013, regional authorities have been in charge of purchasing all necessary HIV drugs. However, procurement decentralization resulted in constant shortages of medications in many Russian regions.
A Message from The Moscow Times:
Dear readers,
We are facing unprecedented challenges. Russia's Prosecutor General's Office has designated The Moscow Times as an "undesirable" organization, criminalizing our work and putting our staff at risk of prosecution. This follows our earlier unjust labeling as a "foreign agent."
These actions are direct attempts to silence independent journalism in Russia. The authorities claim our work "discredits the decisions of the Russian leadership." We see things differently: we strive to provide accurate, unbiased reporting on Russia.
We, the journalists of The Moscow Times, refuse to be silenced. But to continue our work, we need your help.
Your support, no matter how small, makes a world of difference. If you can, please support us monthly starting from just $2. It's quick to set up, and every contribution makes a significant impact.
By supporting The Moscow Times, you're defending open, independent journalism in the face of repression. Thank you for standing with us.
Remind me later.
